Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Twice-Daily Systane Complete Versus Four-Times-Daily Thealoz Duo for Dry Eye Disease
NCT07722650Completed
- Sponsor
- Instituto Internacional de Medicina y Terapia
- Start
- Jan 2025
- Primary completion
- Jun 2025
- Countries
- 1
01
Overview
Randomised trial of propylene glycol-hydroxypropyl guar nanoemulsion in dry eye disease (DED) (2 arms), sponsored by Instituto Internacional de Medicina y Terapia. Primary endpoint: Ocular Surface Disease Index at 30 days. Started Jan 2025; status: completed.
02
Drugs
propylene glycol-hydroxypropyl guar nanoemulsion
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT07722650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07722650.